ReNeuron Group plc Creditor’s decision on Administrators' Proposals
June 05 2024 - 10:36AM
RNS Regulatory News
RNS Number : 2808R
ReNeuron Group plc
05 June 2024
5 June 2024
ReNeuron Group plc
("ReNeuron" or the "Company")
Notice of Creditor's decision
on Joint Administrators' Proposals
Further to the announcement of the
publication of the Joint Administrators' Proposals on 17 May 2024,
ReNeuron Group plc (in administration) (AIM: RENE), a UK based
leader in stem cell derived exosome technologies, announces that
Mark Smith and Stephen Cork of Cork Gully LLP, the Joint
Administrators of the Company and of its subsidiaries, ReNeuron
Limited, ReNeuron (UK) Limited ReNeuron Holdings Limited (All in
Administration) (together the "Group") have filed the "AM07 -
Notice of creditor's decision on administrator's proposals" at
Companies House. The notice will be published by Companies House in
due course.
The notice documents that, at 23:59
hours on 30 May 2024, all decisions were duly approved by
creditors.
Further updates on the
administration process will be made when appropriate
Enquiries:
|
Cork
Gully LLP
|
+44 (0)20
7268 2150 or
|
|
Stephen Cork, Joint
Administrator
|
reneuron@corkgully.com
|
|
Mark Smith, Joint
Administrator
|
|
|
|
|
|
ReNeuron
|
www.reneuron.com/investors
|
|
Iain Ross, Executive
Chairman
|
Via
Walbrook PR
|
|
|
|
|
|
|
|
Allenby Capital Limited (Nominated Adviser and
Broker)
|
+44 (0)20
3328 5656
|
|
James Reeve/George Payne/Dan
Dearden-Williams (Corporate Finance)
|
|
|
Stefano Aquilino/Kelly Gardiner
(Sales & Corporate Broking)
|
|
|
|
|
|
Walbrook PR (Media & Investor Relations)
|
+44 (0)20
7933 8780 or reneuron@walbrookpr.com
|
|
Paul McManus / Alice
Woodings
|
+44
(0)7980 541 893 / +44 (0)7407 804 654
|
|
|
|
| |
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
MSCBSGDLUXGDGSU
Reneuron (LSE:RENE)
Historical Stock Chart
From Nov 2024 to Dec 2024
Reneuron (LSE:RENE)
Historical Stock Chart
From Dec 2023 to Dec 2024
